硬皮病以患者为中心的干预网络(SPIN)队列中焦虑症状及其相关因素:一项横断面研究
该研究纳入2463例系统性硬化症(SSc)患者,比较其焦虑症状T评分与美国一般人群常模的差异,并采用多变量线性回归分析社会人口学、生活方式及疾病相关因素与焦虑症状的关联。结果显示患者平均焦虑T评分为52.6(标准差10.0,95%CI 52.2,53.0),略高于美国一般人群均值50,但仍处于正常范围内;焦虑症状与较年轻年龄、女性、非已婚状态、非白人种族或族裔、居住在加拿大/英国/法国(对比美国)、较高BMI、距非雷诺症状出现时间较短、胃肠道受累、中度小关节挛缩、无间质性肺病及舍格伦病相关。
要点
- SSc患者平均焦虑T评分为52.6,较美国常模均值50高约1/3个标准差,但仍在正常范围内。
- 焦虑症状与较年轻年龄、女性、非已婚、非白人、居住在加拿大/英国/法国(对比美国)相关。
- 胃肠道受累、中度小关节挛缩、无间质性肺病及舍格伦病与较高焦虑T评分相关。
核心结论
- SSc患者的焦虑症状有所升高,且与多个社会人口学和疾病因素相关。
研究设计与样本
- 横断面研究,纳入硬皮病以患者为中心的干预网络(SPIN)队列中2463例系统性硬化症(SSc)患者,入组时完成PROMIS第2版4a焦虑域评估。
- PROMIS域评分采用T评分(均值=50,标准差=10),以美国常模样本校准;比较患者T评分与美国常模,并采用多变量线性回归评估社会人口学、生活方式及医生报告的疾病相关变量与焦虑的关联。
主要发现
- 2463例SSc患者平均焦虑症状T评分为52.6(标准差10.0,95%CI 52.2,53.0),较美国一般人群均值50(标准差10)高约1/3个标准差,但仍在正常范围内。
- 较高T评分与较年轻年龄相关(每10年1.07个T评分点,95%CI 0.74,1.40),与女性相关(1.81,95%CI 0.63,3.00),与非已婚状态相关(0.99,95%CI 0.14,1.84),与非白人种族或族裔相关(1.79,95%CI 0.72,2.85)。
- 较高T评分与居住在加拿大(1.70,95%CI 0.61,2.79)、英国(1.53,95%CI 0.06,2.99)或法国(2.01,95%CI 0.98,3.03)(对比美国)相关,与较高BMI相关(0.11,95%CI 0.03,0.17),与距非雷诺症状出现时间较短相关(每10年0.82,95%CI 0.40,1.30)。
- 较高T评分与胃肠道受累相关(2.70,95%CI 1.52,3.88),与中度小关节挛缩相关(1.24,95%CI 0.10,2.38),与无间质性肺病相关(0.93,95%CI -1.79,-0.07),与舍格伦病相关(1.67,95%CI 0.17,3.17)。
- 在纳入与焦虑可能存在双向通路的变量的敏感性分析中,焦虑还与瘙痒和疼痛强度相关。
关键数值与推荐
- PROMIS域评分采用T评分,均值=50,标准差=10,以美国常模样本校准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We (1) compared anxiety symptom levels in a multinational SSc cohort to a general population normative sample and (2) evaluated sociodemographic, lifestyle and SSc disease factors associated with symptoms. METHODS: Scleroderma Patient-centered Intervention Network Cohort participants completed the Patient-Reported Outcomes Measurement Information System (PROMIS) Version 2 4a Anxiety domain upon enrolment. PROMIS domain scores use T-scores (mean = 50, S.D. = 10) calibrated to a United States normative sample. We compared T-scores to the PROMIS United States normative sample and, in SSc, assessed associations of sociodemographic, lifestyle and physician-reported disease-related variables with multivariable linear regression. RESULTS: Among 2463 participants with SSc, mean anxiety symptom T-score (52.6, S.D. = 10.0, 95% CI 52.2, 53.0) was ∼1/3 S.D. higher than the United States general population mean of 50 (S.D. = 10), though within normal limits. Higher T-scores were associated with younger age (1.07 T-score points per 10 years, 95% CI 0.74, 1.40), female sex (1.81, 95% CI 0.63, 3.00), non-married status (0.99, 95% CI 0.14, 1.84), race or ethnicity other than White (1.79, 95% CI 0.72, 2.85), living in Canada (1.70, 95% CI 0.61, 2.79), the United Kingdom (1.53, 95% CI 0.06, 2.99) or France (2.01, 95% CI 0.98, 3.03) (vs the United States), higher BMI (0.11, 95% CI 0.03, 0.17), less time since non-Raynaud's symptom onset (0.82 per 10 years, 95% CI 0.40, 1.30), gastrointestinal involvement (2.70, 95% CI 1.52, 3.88), moderate small joint contractures (1.24, 95% CI 0.10, 2.38), the absence of interstitial lung disease (0.93, 95% CI -1.79, -0.07) and Sjögren disease (1.67, 95% CI 0.17, 3.17). Interstitial lung disease was not statistically significant when accounting for an interaction with country. Anxiety was also associated with pruritus and pain intensity in a sensitivity analysis that included variables with possible bi-directional pathways with anxiety. CONCLUSION: Anxiety symptoms were somewhat elevated among individuals with SSc and associated with multiple sociodemographic and disease factors.
引用
- Provencher S, Carrier ME, Virgili-Gervais G, et al. Anxiety symptoms and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a cross-sectional study. Rheumatology (Oxford). 2025. PMID: 40802523. doi:10.1093/rheumatology/keaf374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。